Parexel supports the development of innovative new medicines to improve the health of patients. We provide services to help life sciences and biopharmaceutical clients everywhere transform scientific discoveries into new treatments. From decentralized clinical trials to regulatory consulting services to leveraging real world insights, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do. Parexel was named “Best Contract Research Organization” in December 2020 by an independent panel for Informa Pharma Intelligence.

C-Suite On Deck

Responsive image

Q&A with Cecil Nick, Vice President at Parexel

Media 7 | August 2, 2021

Cecil Nick, Vice President (Biotechnology) at Parexel, is a biochemistry graduate and regulatory professional with over 30 years experience specializing in the clinical development of biological and biotech products. He has supported 7 biosimilar marketing approvals and has over 80 biosimilar Agency interactions in EU, US, Canada and RoW. He offers extensive expertise to clients with respect to biosimilars, comparabilty, clinical development, orphan drugs and training. He is a fellow of TOPRA and has been a guest lecture at Cardiff University for MSc in Clinical Research, and Greenwich University for MSc in Pharmaceutical Sciences, courses and Biotech Module leader for the TOPRA MSc course. He was on the editorial panel of SCRIP Clinical Research and has over 30 publications to his name.

Read More

Events

Related News

Medical Devices

CELONOVA ANNOUNCES NEW STRATEGIC DIRECTION FOCUSED ON CREATING PARTNERSHIP

CeloNova BioSciences, Inc. | April 08, 2022

news image

CeloNova BioSciences, Inc. developer and manufacturer of a portfolio of novel surfaced coated technologies, including the proprietary Polyzene™-F nanocoating, announced the strategic decision to focus its core business on creating partnership and co-development opportunities with medical device manufacturers seeking to optimize implant interaction within the body. The company's nanocoated innovation is the result of years of rigorous scientific research and engineering and has been ...

Read More

Digital Healthcare

BEEKEEPERAI ANNOUNCES COMMERCIAL RELEASE OF ITS PATENTED, ZERO-TRUST COLLABORATION PLATFORM TO ACCELERATE HEALTHCARE AI DEVELOPMENT

Businesswire | May 22, 2023

news image

BeeKeeperAI, Inc., a pioneer in zero-trust, real-world data collaboration software, announced the general availability of EscrowAITM, a patent-protectedi zero-trust collaboration platform. EscrowAI leverages Azure confidential computing to resolve the challenges of data sovereignty, privacy, and security. In healthcare, EscrowAI enables HIPAA-compliant research on full PHI without exposing the patient data, thereby reducing the AI development timeline dramatically due to streamlined ...

Read More

Digital Healthcare

ONESHARE HEALTH PARTNERS WITH TECHNOLOGY CARE PROVIDER CLEVER HEALTH™ TO BENEFIT MEMBERS

OneShare Health | December 06, 2021

news image

OneShare Health, a Health Care Sharing Ministry (HCSM) of Irving, TX, and health technology company Clever Health™ of Scottsdale, AZ, announced that the HCSM's switch from traditional telehealth services to Smart Virtual CareTM has reduced actual costs by 81% and total time for Member care by 90% from start to finish. These results are directly attributed to new app technology provided by Clever Health™ that enables OneShare Health Members to provide health inf...

Read More

ALLSCRIPTS STREAMLINES TELEHEALTH IMPLEMENTATION DURING COVID-19

HITInfrastructure | March 31, 2020

news image

Allscripts annnounced it has created a specialized telehealth implementation plan for clients to implement virtual visits between providers and patients through its EHR-agnostic patient engagement platform. The platform, FollowMyHealth, will allow clients across the nation to sign up and telehealth visit capabilities in a quick timeframe to their patients. With our telehealth offering through the robust FollowMyHealth platform, Allscripts is helping clients adapt to the evolving healthcare envir...

Read More
news image

Medical Devices

CELONOVA ANNOUNCES NEW STRATEGIC DIRECTION FOCUSED ON CREATING PARTNERSHIP

CeloNova BioSciences, Inc. | April 08, 2022

CeloNova BioSciences, Inc. developer and manufacturer of a portfolio of novel surfaced coated technologies, including the proprietary Polyzene™-F nanocoating, announced the strategic decision to focus its core business on creating partnership and co-development opportunities with medical device manufacturers seeking to optimize implant interaction within the body. The company's nanocoated innovation is the result of years of rigorous scientific research and engineering and has been ...

Read More
news image

Digital Healthcare

BEEKEEPERAI ANNOUNCES COMMERCIAL RELEASE OF ITS PATENTED, ZERO-TRUST COLLABORATION PLATFORM TO ACCELERATE HEALTHCARE AI DEVELOPMENT

Businesswire | May 22, 2023

BeeKeeperAI, Inc., a pioneer in zero-trust, real-world data collaboration software, announced the general availability of EscrowAITM, a patent-protectedi zero-trust collaboration platform. EscrowAI leverages Azure confidential computing to resolve the challenges of data sovereignty, privacy, and security. In healthcare, EscrowAI enables HIPAA-compliant research on full PHI without exposing the patient data, thereby reducing the AI development timeline dramatically due to streamlined ...

Read More
news image

Digital Healthcare

ONESHARE HEALTH PARTNERS WITH TECHNOLOGY CARE PROVIDER CLEVER HEALTH™ TO BENEFIT MEMBERS

OneShare Health | December 06, 2021

OneShare Health, a Health Care Sharing Ministry (HCSM) of Irving, TX, and health technology company Clever Health™ of Scottsdale, AZ, announced that the HCSM's switch from traditional telehealth services to Smart Virtual CareTM has reduced actual costs by 81% and total time for Member care by 90% from start to finish. These results are directly attributed to new app technology provided by Clever Health™ that enables OneShare Health Members to provide health inf...

Read More
news image

ALLSCRIPTS STREAMLINES TELEHEALTH IMPLEMENTATION DURING COVID-19

HITInfrastructure | March 31, 2020

Allscripts annnounced it has created a specialized telehealth implementation plan for clients to implement virtual visits between providers and patients through its EHR-agnostic patient engagement platform. The platform, FollowMyHealth, will allow clients across the nation to sign up and telehealth visit capabilities in a quick timeframe to their patients. With our telehealth offering through the robust FollowMyHealth platform, Allscripts is helping clients adapt to the evolving healthcare envir...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Q&A with Cecil Nick, Vice President at Parexel

Media 7 | August 2, 2021

Cecil Nick, Vice President (Biotechnology) at Parexel, is a biochemistry graduate and regulatory professional with over 30 years experience specializing in the clinical development of biological and biotech products. He has supported 7 biosimilar marketing approvals and has over 80 biosimilar Agency interactions in EU, US, Canada and RoW. He offers extensive expertise to clients with respect to biosimilars, comparabilty, clinical development, orphan drugs and training. He is a fellow of TOPRA and has been a guest lecture at Cardiff University for MSc in Clinical Research, and Greenwich University for MSc in Pharmaceutical Sciences, courses and Biotech Module leader for the TOPRA MSc course. He was on the editorial panel of SCRIP Clinical Research and has over 30 publications to his name.

Read More